Neurodevelopmental outcome in infants with bronchopulmonary dysplasia. 1992

J Bregman, and E E Farrell
Evanston Hospital, Illinois.

It appears that the survivor of BPD is at risk for neurodevelopmental compromise but not necessarily to any greater extent than are prematurely born infants in general. What appears to be true is that as the neonatal course becomes more complicated, and the birth weight drops, the risk increases. If a BPD survivor sustains a moderate to severe IVH, particularly if accompanied by periventricular leukomalacia, the risk of significant handicap increases substantially. Effects of socioeconomic status (SES) are also important, and become more evident over time with a direct correlation between SES and outcome. Maximizing the environmental conditions while in the special care nursery, and reducing stress on the infant during the illness, may help to reduce risk of a compromised developmental outcome in the survivors. Careful monitoring of oxygen saturation postdischarge may similarly have a positive effect on outcome. Although direct comparability among studies is not possible, it appears that most reports suggest about half the survivors are free of any handicapping condition at follow-up, and about half are either moderately or severely impaired. Cerebral palsy is the most frequently reported handicapping condition. Since the presence or absence of significant IVH is not consistently reported across studies, it is not possible to know if infants who subsequently develop CP sustained a bleed, in addition to BPD, in the neonatal period. In studies in which this is more carefully delineated, that appears to be the case. In studies in which infants with significant hemorrhage were either excluded or dropped out, no survivors with cerebral palsy are reported. Approximately 4% of survivors across all studies reviewed were blind as a result of severe retinopathy of prematurity. Several studies excluded infants who developed significant ROP from their follow-up, so this percentage may be an underestimate of the actual incidence across all BPD survivors. With a greater number of gestationally younger infants surviving, this is one area of handicap that may increase in the years to come. Not all studies report on the presence of sensorineural hearing loss in survivors, but there is the suggestion this may occur perhaps in up to 4% of survivors. This is an area that future research should address. For infants who fall in the moderately handicapped category, typically defined as more than one standard deviation below the mean on a standardized developmental examination, that rating may change over time in either direction.(ABSTRACT TRUNCATED AT 400 WORDS)

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D012121 Respiration, Artificial Any method of artificial breathing that employs mechanical or non-mechanical means to force the air into and out of the lungs. Artificial respiration or ventilation is used in individuals who have stopped breathing or have RESPIRATORY INSUFFICIENCY to increase their intake of oxygen (O2) and excretion of carbon dioxide (CO2). Ventilation, Mechanical,Mechanical Ventilation,Artificial Respiration,Artificial Respirations,Mechanical Ventilations,Respirations, Artificial,Ventilations, Mechanical
D001997 Bronchopulmonary Dysplasia A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS. Dysplasia, Bronchopulmonary
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002658 Developmental Disabilities Disorders in which there is a delay in development based on that expected for a given age level or stage of development. These impairments or disabilities originate before age 18, may be expected to continue indefinitely, and constitute a substantial impairment. Biological and nonbiological factors are involved in these disorders. (From American Psychiatric Glossary, 6th ed) Child Development Deviations,Child Development Disorders,Child Development Disorders, Specific,Developmental Delay Disorders,Disabilities, Developmental,Development Disorders, Child,Child Development Deviation,Child Development Disorder,Development Deviation, Child,Development Deviations, Child,Development Disorder, Child,Developmental Delay Disorder,Developmental Disability,Deviation, Child Development,Disability, Developmental
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006130 Growth Disorders Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth. Stunted Growth,Stunting,Disorder, Growth,Growth Disorder,Growth, Stunted,Stuntings

Related Publications

J Bregman, and E E Farrell
November 1995, Archives of disease in childhood. Fetal and neonatal edition,
J Bregman, and E E Farrell
June 1991, The American journal of the medical sciences,
J Bregman, and E E Farrell
August 2006, Seminars in perinatology,
J Bregman, and E E Farrell
November 2021, Pediatric pulmonology,
J Bregman, and E E Farrell
June 2014, Acta bio-medica : Atenei Parmensis,
J Bregman, and E E Farrell
July 1991, American journal of diseases of children (1960),
J Bregman, and E E Farrell
March 2022, European review for medical and pharmacological sciences,
J Bregman, and E E Farrell
October 2016, Journal of perinatology : official journal of the California Perinatal Association,
J Bregman, and E E Farrell
September 2013, European journal of pediatrics,
Copied contents to your clipboard!